Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases

Details for Australian Patent Application No. 2003290651 (hide)

Owner Celgene Corporation

Inventors Zeldis, Jerome B.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2003290651

PCT Number PCT/US2003/0355

PCT Pub. Number WO2004/043377

Priority 10/438,213 15.05.03 US; 60/424,600 06.11.02 US

Filing date 6 November 2003

Wipo publication date 3 June 2004

Acceptance publication date 31 January 2008

International Classifications

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/00 (2006.01)

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/425 (2006.01) - Thiazoles

A61K 31/454 (2006.01)

A61K 31/515 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

8 April 2004 Complete Application Filed

  Priority application(s): 10/438,213 15.05.03 US; 60/424,600 06.11.02 US

8 July 2004 Application Open to Public Inspection

  Published as AU-B-2003290651

31 January 2008 Application Accepted

  Published as AU-B-2003290651

29 May 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003290652-Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases

2003290650-METHOD AND DEVICE FOR ELECTROCHEMICALLY BUILDING OF MUSCLE